Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Novel agents for thrombotic disorders prepared and tested

Aug. 9, 2005

Data describing pharmacodynamic profile of TGN-255 presented

Aug. 9, 2005

Antithrombotic activity of DU-176b described in several animal models

Aug. 9, 2005

Prasugrel decreases the incidence of cardiac events in patients undergoing PCI

Aug. 8, 2005

Japanese approval for Cleactor for acute pulmonary embolism

Aug. 3, 2005

PAI-1 inhibitors in early development at Wyeth for thrombotic disorders

Aug. 2, 2005

Recent Wyeth patents report novel agents for thrombotic disorders

July 26, 2005

Mitsubishi launches argatroban as first solely marketed product in Europe

July 22, 2005

Hydroxyurea reduces vascular event risk more than anagrelide in essential thrombocythemia

July 22, 2005

Novel antithrombotic agents reported in recent patent literature

July 19, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...